SILVERARC CAPITAL MANAGEMENT, LLC – Celldex Therapeutics, Inc. Transaction History
SILVERARC CAPITAL MANAGEMENT, LLC portfolio value:
$0
portfolio value
Celldex Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +46.67% | 16.95K shares | 519K | $28.11 | 53.27K |
Q3 2022 | put | Decrease | -100.00% | -36K shares | -971K | $28.11 | 0 |
Q2 2022 | share | Decrease | -20.24% | -9.21K shares | 723K | $26.96 | 36.32K |
Q2 2022 | put | Increase | 0.00% | 36K shares | 971K | $26.96 | 36K |
Q1 2022 | share | Increase | +0.90% | 406 shares | -1.48M | $34.06 | 45.53K |
Q4 2021 | share | Increase | +18.01% | 6.88K shares | -321K | $38.9 | 45.13K |
Q3 2021 | share | Increase | +285.48% | 28.32K shares | -861K | $53.99 | 38.24K |
Q2 2021 | share | Increase | 0.00% | 9.92K shares | 2.92M | $33.44 | 9.92K |
Q1 2021 | share | Decrease | -100.00% | -80.28K shares | -1.40M | $20.6 | 0 |
Q4 2020 | share | Increase | 0.00% | 80.28K shares | 1.40M | $17.52 | 80.28K |